ESR1 and breast cancer: Moreover, a variety of BC cell receptors including estrogen receptors, CD44, transferrin-receptor, avb3 Integrin, biotin receptor, TRAIL receptor, and luteinizing hormone releasing hormone (LHRH) or gonadotropin-releasing hormone (GnRH) were developed for delivering ligand-tagged therapeutic NPs [7].